Newsfeeds - Spark Newswire - Page 8

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

3 minute read

FDA
News

AstraZeneca Announced Orpathys Approved in China for Lung Cancer

By Charles Gross

Today, 2:02 PM

AstraZeneca (NYSE: AZN) and HUTCHMED's (NASDAQ: HCM) Orpathys (savolitinib) has been granted conditional approval in China to treat patients with non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations who have progressed following prior syste

Read More

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 2:02 PM

Gainers

Read More

1 minute read

Hutchmed Files For Over $600M Hong Kong IPO

By Vandana Singh

Today, 2:02 PM

Hutchmed (China) Limited (NASDAQ:HCM) will look to raise $603 million as part of a Hong Kong IPO, listed in the…

Read More

4 minute read

70 Biggest Movers From Yesterday

Today, 2:02 PM

Gainers Genprex, Inc. (NASDAQ:GNPX) shares surged 64.4% to close at $1.89 on Wednesday after climbing 219.44% on Tuesday.…

Read More

1 minute read

Chi-Med Prices 4.4M Public Offering of ADSs @$25/ADS

By Charles Gross

Today, 2:02 PM

Hutchison China MediTech Limited (“Chi-Med”) (NASDAQ:HCM) announced today the pricing of the underwritten public offering previously announced by…

Read More

7 minute read

116 Healthcare Stocks Moving In Wednesday’s Session

By Benzinga Newsdesk

Today, 2:02 PM

Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock moved upwards by 133.1% to $3.38 during Wednesday’s regular session. • Genprex,…

Read More

3 minute read

46 Stocks Moving In Wednesday’s Mid-Day Session

Today, 2:02 PM

Gainers Neurotrope, Inc. (NASDAQ:NTRP) shares jumped 114.5% to $3.11 after the company announced it was awarded $2.7 million…

Read More

1 minute read

News

Chi-Med Announces that Surufatinib Phase III SANET-p Study Has Already Achieved its Primary Endpoint in Advanced Pancreatic Neuroendocrine Tumors in China and Will Stop Early

By Charles Gross

Today, 2:02 PM

Hutchison China MediTech Limited (“Chi-Med”) (NASDAQ:HCM) today announces that the independent Data Monitoring Committee (“IDMC”) of the Phase…